ÇELİK, M. Et Al. 2024. Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients. Medicine (United States) , vol.103, no.41 .

ÇELİK, M., TEKİN, E., KOÇAK, M. N., Uzunçakmak, S. K., & BAYRAKTAR, M., (2024). Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients. Medicine (United States) , vol.103, no.41.

ÇELİK, Muhammet Et Al. "Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients," Medicine (United States) , vol.103, no.41, 2024

ÇELİK, Muhammet Et Al. "Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients." Medicine (United States) , vol.103, no.41, 2024

ÇELİK, M. Et Al. (2024) . "Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients." Medicine (United States) , vol.103, no.41.

@article{article, author={Muhammet ÇELİK Et Al. }, title={Unveiling the significance of Gremlin-1 as a novel biomarker for enhanced severity prediction in COVID-19 patients}, journal={Medicine (United States)}, year=2024}